Athul Raj Raju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Athul Raj Raju has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Rupak Desai
Atlanta VA Medical Center, Decatur, GA
2 shared publications - Akhil Jain
The University of Texas MD Anderson Cancer Center 1 Department of Leukemia Houston, Texas
1 shared publication - Chintan Rupareliya
Univ of Kentucky, Lexington, KY
1 shared publication Confesora Valdez
Universidad Autónoma de Santo Domingo, Santo Domingo, Dominican Republic
1 shared publication- Elliot Hwang
Department of Cardiology, Marshfield Clinic Health System , 1000 N Oak Ave, Marshfield, WI
1 shared publication Geethu Jnaneswaran
SUT Academy Of Med Sciences, Thiruvananthapuram, India
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Acute incomplete pulmonary vein isolation and unintended posterior wall ablation during pulsed field ablation: insights from high-density mapping
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Open AccessAcute incomplete pulmonary vein isolation and unintended posterior wall ablation during pulsed field ablation: insights from high-density mapping
- Open Access
- 1 January 2023
- Published by XMLink in International Journal of Heart Failure
- Vol. 5 (4) , 191-200
In-hospital Outcomes of Aspiration Pneumonia Hospitalizations With Acute Heart Failure: A Nationwide Analysis
Jain A, et al. Int J Heart Fail. 2023 Jul;5:e20. https://doi.org/10.36628/ijhf.2023.0014
- 1 January 2023
- Published by XMLink in International Journal of Heart Failure
- Vol. 5 (4) , 191-200
Open AccessIn-hospital Outcomes of Aspiration Pneumonia Hospitalizations With Acute Heart Failure: A Nationwide Analysis
Jain A, et al. Int J Heart Fail. 2023 Jul;5:e20. https://doi.org/10.36628/ijhf.2023.0014
- 1 February 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (Suppl_1)
Abstract WMP49: Higher Risk Of Stroke Recurrence With Increased Plasma D-dimer Levels: A Systematic Review And Meta-analysis
Background: D-dimer has been evaluated as an independent marker of ischemic stroke. The non-existence of a clear consensus and pooled data about the use of D-dimer as a predictive biomarker for assessing the risk of stroke recurrence led us to perform this systematic review and meta-analysis. Methods: Studies reporting the risk of stroke recurrence with varying degrees of high D-dimer levels were screened through August 2021 using PubMed/Medline, Scopus, EMBASE and Web of Science databases and relevant keywords. Random effects models by Dersimonian & Laird were used for meta-analysis and subgroup analysis. I2 statistics were used for heterogeneity assessment. The leave-one-out method was used for sensitivity analysis. Results: This systematic review included 5040 patients from 9 studies consisting of >60% males. There was a high burden of cardiovascular comorbidities, smoking and diabetes in stroke patients with or without associated diagnoses and high D-dimer levels. Compared to low D-dimer levels, higher plasma D-dimer levels were associated with ~80% (aOR 1.79, 95% CI: 1.24-2.59) increased risk of stroke recurrence. The odds of stroke recurrence were significantly high in the stroke cohorts including patients with mean age Conclusion: This meta-analysis showed that high D-dimer levels were associated with nearly 80% higher odds of stroke recurrence irrespective of the etiology of index stroke events. Stronger associations were seen in studies with a mean age <70 years and a higher sample size. Late-onset recurrence had a stronger association with high D-dimer levels compared to early-onset. Download figure
- 1 February 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (Suppl_1)
Abstract WMP49: Higher Risk Of Stroke Recurrence With Increased Plasma D-dimer Levels: A Systematic Review And Meta-analysis
Background: D-dimer has been evaluated as an independent marker of ischemic stroke. The non-existence of a clear consensus and pooled data about the use of D-dimer as a predictive biomarker for assessing the risk of stroke recurrence led us to perform this systematic review and meta-analysis. Methods: Studies reporting the risk of stroke recurrence with varying degrees of high D-dimer levels were screened through August 2021 using PubMed/Medline, Scopus, EMBASE and Web of Science databases and relevant keywords. Random effects models by Dersimonian & Laird were used for meta-analysis and subgroup analysis. I2 statistics were used for heterogeneity assessment. The leave-one-out method was used for sensitivity analysis. Results: This systematic review included 5040 patients from 9 studies consisting of >60% males. There was a high burden of cardiovascular comorbidities, smoking and diabetes in stroke patients with or without associated diagnoses and high D-dimer levels. Compared to low D-dimer levels, higher plasma D-dimer levels were associated with ~80% (aOR 1.79, 95% CI: 1.24-2.59) increased risk of stroke recurrence. The odds of stroke recurrence were significantly high in the stroke cohorts including patients with mean age Conclusion: This meta-analysis showed that high D-dimer levels were associated with nearly 80% higher odds of stroke recurrence irrespective of the etiology of index stroke events. Stronger associations were seen in studies with a mean age <70 years and a higher sample size. Late-onset recurrence had a stronger association with high D-dimer levels compared to early-onset. Download figure